Ignite Creation Date:
2024-05-06 @ 2:56 PM
Last Modification Date:
2024-10-26 @ 1:40 PM
Study NCT ID:
NCT04479241
Status:
COMPLETED
Last Update Posted:
2023-09-28
First Post:
2020-07-16
Brief Title:
LUMINOS-101 Lerapolturev PVSRIPO and Pembrolizumab in Patients with Recurrent Glioblastoma
Sponsor:
Istari Oncology Inc
Organization:
Istari Oncology Inc
Organization Data
Organization:
Istari Oncology Inc
Class:
INDUSTRY
Study ID:
LUMINOS-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Istari Oncology Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None